Genome-wide DNA methylation profiles in urothelial carcinomas and urothelia at the precancerous stage

Cancer Science

Volumn 101, Issue 1, 2010, Pages 231-240

  Nishiyama, Naotaka ^a,b   Arai, Eri ^a   Chihara, Yoshitomo ^a   Fujimoto, Hiroyuki ^c   Hosoda, Fumie ^a   Shibata, Tatsuhiro ^a   Kondo, Tadashi ^a   Tsukamoto, Taiji ^b   Yokoi, Sana ^d   Imoto, Issei ^d   Inazawa, Johji ^d   Hirohashi, Setsuo ^a   Kanai, Yae ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER GROWTH; CANCER INVASION; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; FEMALE; GENETIC RISK; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; URINARY TRACT CARCINOMA; UROTHELIAL CARCINOMA;

AGED; AGED, 80 AND OVER; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; URINARY BLADDER NEOPLASMS;

EID: 71849096572     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01330.x     Document Type: Article

References (39)

1. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002, 3:415-28.
2. Eden A, Gaudet F, Waghmare A, Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003, 300:455.
3. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006, 6:107-16.
4. Gronbaek K, Hother C, Jones PA. Epigenetic changes in cancer. Apmis 2007, 115:1039-59.
5. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature 2007, 447:433-40.
6. Kanai Y, Hirohashi S. Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis 2007, 28:2434-42.
7. Kanai Y. Alterations of DNA methylation and clinicopathological diversity of human cancers. Pathol Int 2008, 58:544-8.
8. Nakagawa T, Kanai Y, Saito Y, Kitamura T, Kakizoe T, Hirohashi S. Increased DNA methyltransferase 1 protein expression in human transitional cell carcinoma of the bladder. J Urol 2003, 170:2463-6.
9. Nakagawa T, Kanai Y, Ushijima S, Kitamura T, Kakizoe T, Hirohashi S. DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis. J Urol 2005, 173:1767-71.
10. Nakagawa T, Kanai Y, Ushijima S, Kitamura T, Kakizoe T, Hirohashi S. DNA hypomethylation on pericentromeric satellite regions significantly correlates with loss of heterozygosity on chromosome 9 in urothelial carcinomas. J Urol 2005, 173:243-6.
11. Kakizoe T, Tobisu K, Takai K, Tanaka Y, Kishi K, Teshima S. Relationship between papillary and nodular transitional cell carcinoma in the human urinary bladder. Cancer Res 1998, 48:2299-303.
12. Kakizoe T. Development and progression of urothelial carcinoma. Cancer Sci 2006, 97:821-8.
13. Aleman A, Adrien L, Lopez-Serra L. Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays. Br J Cancer 2008, 98:466-73.
14. Estecio MR, Yan PS, Ibrahim AE. High-throughput methylation profiling by MCA coupled to CpG island microarray. Genome Res 2007, 17:1529-36.
15. Jacinto FV, Ballestar E, Ropero S, Esteller M. Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells. Cancer Res 2007, 67:11481-6.
16. Nielander I, Bug S, Richter J, Giefing M, Martin-Subero JI, Siebert R. Combining array-based approaches for the identification of candidate tumor suppressor loci in mature lymphoid neoplasms. Apmis 2007, 115:1107-34.
17. Misawa A, Inoue J, Sugino Y. Methylation-associated silencing of the nuclear receptor I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification. Cancer Res 2005, 65:10233-42.
18. Sugino Y, Misawa A, Inoue J. Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas. Oncogene 2007, 26:7401-13.
19. Tanaka K, Imoto I, Inoue J. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma. Oncogene 2007, 26:6456-68.
20. Inazawa J, Inoue J, Imoto I. Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci 2004, 95:559-63.
21. Lopez-Beltran A, Sauter G, Gasser T, Eble JN, Sauter G, Epstein JI, Sesterhenn IA. Tumours of the urinary system. World Health Organization classification of tumours. Pathology and genetics. Tumours of the urinary system and male genital organs 2004, 89-157. In, ed, Lyon, IARC Press
22. Illingworth R, Kerr A, Desousa D. A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol 2008, 6:e22.
23. Arai E, Ushijima S, Fujimoto H. Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcome. Carcinogenesis 2009, 30:214-21.
24. Manabe D, Saika T, Ebara S. Comparative study of oncologic outcome of laparoscopic nephroureterectomy and standard nephroureterectomy for upper urinary tract transitional cell carcinoma. Urology 2007, 69:457-61.
25. Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 1998, 52:594-601.
26. Harris AL, Neal DE. Bladder cancer - field versus clonal origin. N Engl J Med 1992, 326:759-61.
27. Maruyama R, Toyooka S, Toyooka KO. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res 2001, 15:8659-63.
28. Sathyanarayana UG, Maruyama R, Padar A. Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes. Cancer Res 2004, 15:1425-30.
29. Catto JW, Azzouzi AR, Rehman I. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. J Clin Oncol 2005, 23:2903-10.
30. Yates DR, Rehman I, Abbod MF. Promoter hypermethylation identifies progression risk in bladder cancer. Clin Cancer Res 2007, 13:2046-2053.
31. Kim EJ, Kim YJ, Jeong P, Ha YS, Bae SC, Kim WJ. Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor. J Urol 2008, 180:1141-5.
32. Maekita T, Nakazawa K, Mihara M. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 2006, 12:989-95.
33. Frigola J, Song J, Stirzaker C, Hinshelwood RA, Peinado MA, Clark SJ. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat Genet 2006, 38:540-9.
34. Arai E, Ushijima S, Gotoh M. Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma. Int J Cancer 2009
35. Stein JP, Lieskovsky G, Cote R. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001, 19:666-75.
36. Gallagher DJ, Milowsky MI, Bajorin DF. Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line setting. Cancer 2008, 113:1284-93.
37. Lipponen PK. The prognostic value of basement membrane morphology, tumour histology and morphometry in superficial bladder cancer. J Cancer Res Clin Oncol 1993, 119:295-300.
38. Scrimger RA, Murtha AD, Parliament MB. Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors. Int J Radiat Oncol Biol Phys 2001, 51:23-30.
39. Etoh T, Kanai Y, Ushijima S. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol 2004, 164:689-99.